BIS icon

ProShares UltraShort NASDAQ Biotechnology
BIS

Overview Fund Trends Analyst Outlook Journalist POV

7 hedge funds and large institutions have $858K invested in ProShares UltraShort NASDAQ Biotechnology in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

11.23% more ownership

Funds ownership: 11.58% → 22.81% (+11%)

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$204K
2
+$158K
3
+$148K
4
PIS
POM Investment Strategies
North Carolina
+$75

Top Sellers

1
-$1K
2
-$15
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$465K
2
$232K
3
$158K
4
$1.28K
5
$1.11K
6
$75
7
$15
8
–